An Open Label, Multi-Center, Follow-on Study Examining the Long-Term Safety and Efficacy of Insulin VIAject™ in Subjects With Type 2 Diabetes Mellitus

This study has been completed.
Information provided by (Responsible Party):
Biodel Identifier:
First received: April 2, 2009
Last updated: July 28, 2015
Last verified: July 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2010
  Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: July 28, 2015